Leading Knowledge & Capability
Quay Pharma is unique in both the academic standing of our scientists and our drive to discover the most elegant and effective response, not the first or most obvious, to every challenge of drug delivery and dosage. Our senior commercial and technical team brings together an impressive breadth and depth of experience from academia, the pharmaceutical industry and contract service organisations. Their expertise covers chemistry, analytical chemistry, preclinical and clinical formulation development, pharmaceutical development and quality assurance.
ADD FULL LEADERSHIP LIST - SAME AS PREVIOUS?
Our Leadership Team
Maireadh Pedersen
Chief Executive Officer (CEO)
Maireadh is the Chief Executive Officer of Quay. She brings more than 16 years of experience of business development in an international marketing environment, dealing with the supply of analytical tools and equipment as well as formulation technologies for the pharmaceutical industries. Maireadh’s previous roles include two years as VP with responsibility for Pharmaceutical Business Development at Teraview and eight years at Colorcon managing their EMEA film coating and excipients business.
Professor Larry Gifford
Chief Scientific Officer
Professor Larry Gifford has been appointed as a Chief Scientific Officer. Alongside Professor John Collett. Prof. Gifford joins us from Keele University where he was Deputy Head of the School of Pharmacy. Prior to Keele, Prof. Gifford taught at the University of Manchester and during his final seven years at Manchester was Head of School, whilst leading an EPSRC post-graduate M.Sc. in Pharmaceutical analysis.and his main interests lie in solid dosage form technology and tablet compression.
Melanie Ackerley
Head of Quality
Melanie Ackerley is Quay Pharma’s Head of Quality and has been a releasing QP since 2016. Melanie has a degree in Microbiology and Diploma in Quality Assurance and has worked for 20 years in QA, QC and Validation roles in Pharma covering biologics, steriles, blow fill seal and solid dose. Melanie has held previous roles as Head of Quality, Head of QC and Site Microbiologist at a mix of large Pharma companies, as a consultant and in contract manufacturing.
Dr Alison Foster
Head of Technical - Preclinical
Alison is the Head of Technical for Preclinical Services at Quay Pharmaceuticals. She has a wide breadth of experience having worked previously for Unilever in their cross-category research unit focused on Oral Care and Hair projects, to being one of the founders of a small nanotechnology start-up company focussed on improving bioavailable of poorly soluble drugs. Alison gained Post-Doctoral experience in medicinal chemistry from the School of Pharmacy, the University of Manchester following a PhD in synthetic chemistry. Alison is also co-author of twenty-five patents and nine papers.
Mike Frodsham
Chief Technical Officer (CTO)
Mike is our Chief Technical Officer (CTO). He has 13 years industrial experience in product development and production support roles. Before joining Quay Pharma, his positions included Principal Scientific Officer with SSL International and Development Projects Manager at Galpharm International.
Professor John Collett
Chief Scientific officer
John is Quay Pharma’s Chief Scientific Officer and Professor of Pharmaceutics at the University of Manchester. He has over 30 years of experience in formulation science and is the author of more than 250 research papers. His areas of expertise include the formulation of solubilised and modified release drug delivery systems.